Biomedical Applications of DNA-Conjugated Gold Nanoparticles
Gold nanoparticles (AuNPs) are useful for diagnostic and biomedical applications, mainly because of their ease in preparation and conjugation, biocompatibility, and size‐dependent optical properties. However, bare AuNPs do not possess specificity for targets. AuNPs conjugated with DNA aptamers offer...
Gespeichert in:
Veröffentlicht in: | Chembiochem : a European journal of chemical biology 2016-06, Vol.17 (12), p.1052-1062 |
---|---|
Hauptverfasser: | , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Gold nanoparticles (AuNPs) are useful for diagnostic and biomedical applications, mainly because of their ease in preparation and conjugation, biocompatibility, and size‐dependent optical properties. However, bare AuNPs do not possess specificity for targets. AuNPs conjugated with DNA aptamers offer specificity for various analytes, such as proteins and small molecules/ions. Although DNA aptamers themselves have therapeutic and target‐recognizing properties, they are susceptible to degradation in vivo. When DNA aptamers are conjugated to AuNPs, their stability and cell uptake efficiency both increase, making aptamer–AuNPs suitable for biomedical applications. Additionally, drugs can be efficiently conjugated with DNA aptamer–AuNPs to further enhance their therapeutic efficiency. This review focuses on the applications of DNA aptamer‐based AuNPs in several biomedical areas, including anticoagulation, anticancer, antibacterial, and antiviral applications.
Glittering like gold: Gold nanoparticles are useful for diagnostic and biomedical applications but lack specificity for targets. DNA aptamers have therapeutic and target‐recognizing properties but lack stability in vivo. However, DNA aptamer‐functionalized gold nanoparticles have potential as anticoagulant, anticancer, antibacterial, and antiviral drugs. |
---|---|
ISSN: | 1439-4227 1439-7633 |
DOI: | 10.1002/cbic.201600014 |